Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

8.3%

1 terminated/withdrawn out of 12 trials

Success Rate

90.0%

+3.5% vs industry average

Late-Stage Pipeline

17%

2 trials in Phase 3/4

Results Transparency

0%

0 of 9 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
6(50.0%)
Phase 2
2(16.7%)
Phase 1
2(16.7%)
Phase 3
1(8.3%)
Phase 4
1(8.3%)
12Total
N/A(6)
Phase 2(2)
Phase 1(2)
Phase 3(1)
+1 more

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (12)